

26 Mar 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/03/26/3262853/28908/en/Tonix-Pharmaceuticals-Announces-First-Participant-Dosed-in-Phase-1-Investigator-Initiated-Pharmacodynamic-Study-of-TNX-1900-Intranasal-Potentiated-Oxytocin-to-Assess-Potential-for-.html

04 Mar 2026
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215864

09 Jul 2025
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219196

10 Feb 2025
// BUSINESSWIRE

20 Sep 2024
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213766

11 Apr 2024
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215715